Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization

Oncogene volume 22, pages 4679–4689 (2003)Cite this article

Abstract

Basic studies of oncogenesis have demonstrated that either the elevated production of particular oncogene proteins or the occurrence of qualitative abnormalities in oncogenes can contribute to neoplastic cellular transformation. The purpose of this study was to identify unique oncogenes that are differentially expressed in human cancers and characterize their functions in tumorigenesis. To discover new putative oncogenes, the differential display RT–PCR method was applied using normal cervical tissues, cervical cancer cell lines, cervical cancer tissues, and metastatic tissues. We identified a new human cervical cancer oncogene HCCR-2 that was overexpressed in various human tumors including leukemia, lymphoma, and carcinomas of the breast, kidney, ovary, stomach, colon, and uterine cervix. Ectopic expression of HCCR-2 resulted in direct tumorigenic conversions of NIH/3T3 and Rat1 fibroblasts. Nude mice injected with NIH/3T3 cells stably transfected with HCCR-2 formed tumors in 4 weeks. The resultant tumors display characteristics of an epithelial carcinoma. In HCCR-2 transfected NCI-H460 cells and RKO cells, stabilization of the p53 tumor suppressor occurred without genetic mutation and correlated with functional impairment, as indicated by the defective induction of p53-induced p21WAF1, MDM2, and bax. These results indicate that HCCR-2 probably represents a new oncogene that is related to tumorigenesis, functioning as a negative regulator of the p53 tumor suppressor.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Aaronson SA, Jainchill JL and Todaro GJ . (1970). Proc. Natl. Acad. Sci. USA, 66, 1236–1243.

  • Ahn KY, Madsen KM, Tisher CC and Kone BC . (1991). Am. J. Physiol., 265, F792–F801.

  • Bishop JM . (1991). Cell, 64, 235–248.

  • Buick RN, Fry SE and Salmon SE . (1980). Cancer, 45, 1238–1242.

  • Busby-Earle RMC, Steel CM, Williams ARW, Cohen B and Bird CC . (1994). Br. J. Cancer, 69, 732–737.

  • Cherif D, Julier C, Delattre O, Derre J, Lathrop GM and Berger R . (1990). Proc. Natl. Acad. Sci. USA, 87, 6639–6643.

  • Cooper GM (ed) (1995). Oncogenes. Jones and Bartlett Publishers: Boston.

    Google Scholar 

  • Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ and Vousden KH . (1992). Lancet, 339, 1070–1073.

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B . (1993). Cell, 75, 817–825.

  • Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R and Prives C . (1992). Nature, 358, 83–86.

  • Hubert WG and Lambert PF . (1993). J. Virol., 67, 2932–2937.

  • Huibregtse JM, Scheffner M and Howley PM . (1994). Cold Spring Harber Symp. Quant. Biol., LIX, 237–245.

  • Kim JW, Lee CG, Cho YH, Kim JH, Kim SJ and Kim HK . (1996a). Gynecol. Oncol., 62, 230–240.

  • Kim J, Cha JH, Tisher CC and Madsen KM . (1996b). Am. J. Physiol. Renal Physiol., 270, F575–F592.

  • Leonard CJ, Canman CE and Kastan MB . (1995). Imp. Adv. Oncol., 33–42.

  • McLean IW and Nakane PK . (1974). J. Histochem. Cytochem., 22, 1077–1083.

  • Momand J, Zambetti GP, Olson DC, George D and Levine AJ . (1992). Cell, 69, 1237–1245.

  • Oltval ZN, Milliman CL and Korsmeyer SJ . (1993). Cell, 74, 609–619.

  • Puchtler H and Waldrop FW . (1978). Histochemistry, 57, 177–187.

  • Sambrook J, Fritsch EF and Maniatis T (eds) (1989). Cold Spring Harbor Laboratory: New York.

  • Sarnow P, Ho YS, Williams J and Levine AJ . (1982). Cell, 28, 387–394.

  • Weinberg RA . (1991). Science, 254, 1138–1146.

  • Weinberg RA . (1994). CA Cancer J. Clin., 44, 160–170.

  • Wernes BA, Levine AJ and Howley PM . (1990). Science, 248, 76–79.

  • Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D . (1993). Nature, 366c 701–704.

Download references

Acknowledgements

Supported by a Grant (HMP-99-B-02-0002) of the 1999, Good Health R&D Project, Ministry of Health & Welfare, ROK. We thank JY Jung and W Kim for critically reading the manuscript.

Author information

Authors and Affiliations

  1. Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, 138-736, South Korea

    Jesang Ko & Sung-Wuk Jang

  2. Department of Biochemistry and Molecular Biology, College of Medicine, Yeungnam University, Daegu, 705-717, South Korea

    Young Han Lee

  3. Department of Biochemistry and Molecular Biology, Hanyang University, Ansan, 425-791, South Korea

    Seung Yong Hwang & Jae Hoon Hwang

  4. Department of Clinical Pathology, College of Medicine, The Catholic University of Korea, Seoul, 137-040, South Korea

    Youn Soo Lee

  5. Molecular Genetic Laboratory and Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul, 137-040, South Korea

    Seung Min Shin, Yong Wook Kim, In-Kyung Kim, Sung Eun Namkoong & Jin Woo Kim

  6. Department of Anatomy, College of Medicine, The Catholic University of Korea, Seoul, 137-040, South Korea

    Jin Kim

  7. Laboratory of Animal Science, College of Medicine, The Catholic University of Korea, Seoul, 137-040, South Korea

    Zae Young Ryoo

Authors
  1. Jesang Ko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Young Han Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seung Yong Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Youn Soo Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seung Min Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jae Hoon Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yong Wook Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sung-Wuk Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Zae Young Ryoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. In-Kyung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Sung Eun Namkoong
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Jin Woo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jin Woo Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ko, J., Lee, Y., Hwang, S. et al. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. Oncogene 22, 4679–4689 (2003). https://doi.org/10.1038/sj.onc.1206624

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206624

Keywords

This article is cited by

Search

Advanced search

Quick links